Dr. Charles Isaac Davis Jr., MD Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1615 Parker Ave, Osawatomie, KS 66064 Phone: 913-660-1616 |
News Archive
A new study released today at the American Academy of Allergy, Asthma & Immunology annual conference shows that food allergies are a much more pervasive health challenge than once thought. About 11 million people - roughly 1-in-25 Americans - are now believed to be affected by one or more food allergies, a disease triggered by the ingestion or contact with certain foods that may cause life-threatening reactions, or anaphylaxis, according to The Food Allergy & Anaphylaxis Network (FAAN), a co-investigator of the nationwide survey.
The Chinese Ministry of Health has today reported diagnostic confirmation of SARS infection in two patients previously under investigation in Beijing. Confirmation is based on the results of laboratory tests, clinical symptoms, and a history of close contact with a known case.
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference therapeutics, announced today it has initiated patient dosing in a Phase 1 human clinical trial for its lead oncology product, TKM-PLK1. TKM-PLK1 targets polo-like kinase 1, or PLK1, a cell cycle protein involved in tumor cell proliferation and a validated oncology target.
The new hepatitis C medication presents a dilemma for Medicaid and other insurers, who must balance the cost against the large numbers of people who might benefit. A single course of treatment costs $84,000.
Scientists at Johns Hopkins have surveyed the DNA in four common types of pancreatic cysts, and have determined that each type bears a distinct pattern of gene mutations. Pancreatic cysts are present in about two percent of U.S. adults, and can, in some cases, require surgical removal and microscopic analysis to determine their type and likelihood of turning cancerous.
› Verified 4 days ago